Evaluation of possible prophylactic and therapeutic effect of mefloquine on experimental cryptosporidiosis in immunocompromised mice

Bibliographic Information
Authors: El-Wakil E.S.; Salem A.E.; Al-Ghandour A.M.F.
Journal: Journal of Parasitic Diseases
Publisher: Springer
Publication Date: 13 November 2020
Volume / Issue: Volume 45 / Issue 2
Pages: 380–393
ISSN: 9717196
DOI: 10.1007/s12639-020-01315-4
Scopus: View on Scopus
Document Type: Article
Access: All Open Access; Green Open Access
Authors and Affiliations
El-Wakil E.S., Department of Parasitology, Theodor Bilharz Research Institute, Giza, Egypt; Salem A.E., Department of Clinical Pharmacology, Faculty of Medicine, Zagazig University, Zagazig, Egypt; Al-Ghandour A.M.F., Department of Medical Parasitology, Faculty of Medicine, Zagazig University, Zagazig, Egypt
Abstract
Cryptosporidiosis is an imperative global health concern. Unfortunately, Nitazoxanide (NTZ) (the nowadays drug of choice) is not effective in treatment of immunocompromised patients. We aimed to assess the possible anti-cryptosporidial prophylactic and therapeutic effects of Mefloquine (MQ) on infected immunosuppressed murine models. Mice were divided into five groups; GI: received Mefloquine (400 mg/kg/day), GII: received NTZ (100 mg/kg/bid), GIII: received a combination, half dose regimen of both drugs, GIV: infected untreated and GV: non-infected untreated. Each treated group was divided into three subgroups; Ga prophylaxis (PX), thereafter infection, Gb first and Gc second treatment doses. Assessment was done by parasitological, histopathological and serological techniques. A significant oocyst clearance was detected in all prophylactically treated groups. GIa showed 77% reduction of the mean oocyst count in stool while GIb and GIIIc showed100% oocyst clearance. Histopathologically, the ileocecal sections from GIV showed loss of brush borders with marked villous atrophy. GIa induced a moderate improvement of those pathological changes. Moreover, the villi in GIb and GIIIc retained their normal appearance with minimal inflammatory cells. Serum interferon gamma levels showed highly significant increases in GI&GIII compared to GIV while a non-significant increase was observed in GIIa only. On the contrary, serum interleukin-17 levels showed a highly significant down-regulation in all treated groups in comparison to GIV. This study proved a marvelous effect of MQ-PX on cryptosporidiosis in immunosuppressed mice and thus it could be introduced as one of the most promising re-purposed prophylactic and therapeutic anti-cryptosporidial agents. © 2020, Indian Society for Parasitology.
Keywords
Cryptosporidium; Interferon gamma; Interleukin-17; Mefloquine; Nitazoxanide; Prophylaxis; dexamethasone; gamma interferon; interleukin 17; mephaqin; nanazoxid; animal experiment; animal model; animal tissue; Article; cell hyperplasia; cell infiltration; controlled study; cryptosporidiosis; down regulation; enzyme linked immunosorbent assay; female; goblet cell; histopathology; immunocompromised patient; inflammatory cell; intestine villus atrophy; male; mouse; nonhuman; oocyst; therapy effect; upregulation
Citation Information
Scopus Citations: 25
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
